chr15-40471261-G-A
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_130468.4(CHST14):c.48G>A(p.Glu16Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000339 in 1,475,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_130468.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndrome, musculocontractural type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Ehlers-Danlos syndrome, musculocontractural typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHST14 | ENST00000306243.7 | c.48G>A | p.Glu16Glu | synonymous_variant | Exon 1 of 1 | 6 | NM_130468.4 | ENSP00000307297.6 | ||
CHST14 | ENST00000559991.1 | c.48G>A | p.Glu16Glu | synonymous_variant | Exon 1 of 2 | 5 | ENSP00000453882.1 | |||
ENSG00000302612 | ENST00000788112.1 | n.151+394C>T | intron_variant | Intron 1 of 4 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000127 AC: 1AN: 78506 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000302 AC: 4AN: 1323384Hom.: 0 Cov.: 32 AF XY: 0.00000307 AC XY: 2AN XY: 652410 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74228 show subpopulations
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, musculocontractural type Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at